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1 Membership of the group 
 
Fertility Network UK  
Gwenda Burns – Chief Executive  
 
Aberdeen 
Alison McTavish, Unit Manager, Quality & Business Manager and Nominal HFEA 
License holder, University of Aberdeen/NHS Grampian, Aberdeen Fertility Centre 
Abha Maheshwari, Lead Clinician, Consultant Reproductive Medicine and Person 
Responsible, University of Aberdeen/NHS Grampian, Aberdeen Fertility Centre 
Elizabeth Ferguson, Laboratory Manager, University of Aberdeen/NHS Grampian, 
Aberdeen Fertility Centre  
 
Dundee 
Sarah Martins da Silva, Consultant Obstetrician and Gynaecologist and Person 
Responsible, NHS Tayside, Dundee Assisted Conception Unit 




Joo Thong, Lead Clinician, Consultant Subspecialist in Reproductive 
Medicine/Consultant Gynaecologist and Person Responsible, NHS Lothian, 
Edinburgh Fertility Centre 
Dave Wales, Quality Manager, NHS Lothian, Edinburgh Fertility Centre 
Daniel Collins, Laboratory Manager, NHS Lothian, Edinburgh Fertility Centre 
 
Glasgow  
Helen Lyall, Consultant Gynaecologist and Lead Clinician, NHS GG & C, Glasgow 
Assisted Conception Service   
Joanne Leitch, Lead Embryologist and Person Responsible, NHS GG & C, Glasgow 
Assisted Conception Service   
Scott Nelson, Professor of Obstetrics & Gynaecology, Nominal HFEA License holder 
University of Glasgow, NHS GG & C, Glasgow Assisted Conception Service 
Isobel Traynor, Lead Nurse Assisted Conception & Gynaecology, NHS GG & C, 
Glasgow Assisted Conception Service 
 
Scottish Government  
Sarah Corcoran, Team Leader, Maternal and Infant Health Branch, DCAF 
Louise McCue, Senior Policy Manager, Maternal and Infant Health Branch, DCAF 
Anthea Taylor, Policy Manager, Maternal and Infant Health Branch, DCAF 
 
NHS National Services Scotland 
Carsten Mandt, Senior Programme Manager, Scottish Perinatal Network 
 
Peer reviewed by: Dr Corinne Love, Senior Medical Officer/Maternal and Women’s 
Health, Chief Medical Officer Policy Division, Scottish Government 
 
This document should be read alongside the restart plan and the protocols set out 
there remain the case.  
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After the closure of all fertility clinics in March 2020 due to COVID-19, fertility services 
were given permission to resume in May 2020.  
 
Fertility services restarted in phase 1 of the recovery plan as it was acknowledged 
that it is an extremely time sensitive treatment (https://www.gov.scot/publications/re-
mobilise-recover-re-design-framework-nhs-scotland/pages/9/). In addition, the 
sudden halt to fertility treatments was noted to have added to the distress already 
faced by these patients (Boivin et al., 2020).  The data on COVID-19 and pregnancy 
are still emerging and more details are set out by Royal College of Obstetricians and 
Gynaecologists (RCOG) within Coronavirus (COVID-19), pregnancy and women’s 
health and United Kingdom Obstetrics surveillance system (UKOSS) COVID-19 in 
Pregnancy, with the former updated on a regular basis. Some risks have been 
identified in specific groups, but the data is largely reassuring. 
 
All four NHS tertiary clinics in Aberdeen, Dundee, Edinburgh and Glasgow have 
worked together with Scottish Government and the patient stakeholder group- 
Fertility Network, with twice weekly meetings to create uniform documents and 
policies with a Once for Scotland approachhttps://www.gov.scot/publications/covid-
19-fertility-treatment-scotland-plans-restarting-treatment-framework/. 
 
Whilst the initial COVID-19 surge occurred rapidly, with little time for service 
preparation, there is now an opportunity to prepare for the forthcoming winter, when it 
is anticipated that Fertility services may be affected again. 
 
NHS Fertility services were paused during the initial peak of the pandemic but have 
remained open during subsequent local lockdowns. This document sets out some of 
the issues that might occur in the event of a full lockdown again and how to ensure 
fertility centres provide services through any future local or full lockdowns, with 
appropriate measures being put in place in order support their patients in the most 
efficient and effective way and taking into account the COVID-19 Scotland’s Strategic 
Framework https://www.gov.scot/publications/covid-19-scotlands-strategic-
framework/. Table 1 document sets out an example of prioritisation and Appendix 2 
includes activity in Tiers as per the Framework. 
 
The intention and ambition of the Regulator, the Human Fertilisation and Embryology 
Authority (HFEA) is to avoid closure of licensed fertility services (letter from the HFEA 
Chief Executive, Appendix 1) and the Scottish Government is supportive of this in 
respect of NHS services as set out in this document. 
 
 
3 Predicted situation 
 
As lockdown restrictions eased, it was predicted that there would be a resurgence of 
COVID-19 with local and/or regional outbreaks and this is indeed the current 
experience. There will be the usual winter NHS pressures including seasonal flu and 
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will have implications for policies and procedures in the wider NHS, which will in turn 
affect NHS fertility services.  
 
4 Effect on fertility services 
4.1 Impact from other services: 
 
Although fertility treatment is extremely time sensitive and there is a need to continue 
to provide fertility services, these are not done in isolation. The effect of factors 
highlighted in section 3 on other services such as primary care, general 
Gynaecological services, anaesthetics and testing laboratories, predicts that there 
may potentially be:   
 Reduction in referrals for fertility from primary care 
 Reduced ability of primary care to provide the initial investigations 
 Reduction in referrals from secondary care where secondary care fertility 
services are not provided alongside tertiary services (i.e. clinics which provide 
only secondary care fertility services) 
 Reduction in face to face appointments due to imposed restrictions resulting in 
fewer available appointments for Ultrasound scans, blood tests, semen 
analysis and tubal testing which are essential to determine the appropriate 
treatment pathway 
 Limitation of number of procedures that can be performed in one day due to 
availability of anaesthetists or ward space 
 Delay for those requiring elective Gynaecology surgery prior to fertility 
treatments as is unlikely to be at pre COVID-19 capacity until 2021,  
 Continued pause in donor recruitment will further extend the existing waiting 
time for those requiring treatment with donor gametes 
We are aware that associated services are also putting plans in place to try to 
ensure continuity of service with their own remobilisation plans. 
 
4.2 Shortage of staff 
 
It is anticipated that during winter months there may be a shortage of staff due to: 
 The need to self-isolate due to the member of staff or a member of household 
testing positive for COVID-19 
 The need to self-isolate due to overseas travel, a change in local restriction or 
government policy at short notice 
 COVID-19 risk assessment may impact on patient-facing staffing in NHS 
especially where there are higher proportion of Black and Ethnic minority 
(BAME) staff, staff who had previously been shielding or pregnant workers 
https://www.gov.scot/publications/coronavirus-covid-19-guidance-on-
individual-risk-assessment-for-the-workplace/ 
 Redeployment to other areas/services 
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4.3 Pace of Restart 
 
Although fertility treatments have started across Scotland in all four tertiary clinics, 
the restart has been gradual. This was unavoidable due to the multidisciplinary 
nature of assisted conception and its co-dependence on other medical and laboratory 
specialities. Furthermore, additional processes to mitigate risk of COVID-19 infection 
and transmission and to ensure patient and staff safety were required to be put in 
place prior to commencing treatment. 
  
Before IVF treatment is undertaken, there is a 3-6-week period of patients taking 
medication and undergoing monitoring in preparation of treatment. Hence patients 
who were contacted to advise their treatment was restarting in June, underwent IVF 
treatment in August. All centres initially reopened with reduced capacity and had to 
limit the numbers of patients treated daily in order to ensure safe working practice.  
Should an increase in capacity be achievable, it is anticipated that it will be at least a 
further 6– 9 months before services return to 2019 levels of activity and waiting times, 
provided there are no further restrictions/ lockdown. It is acknowledged that these 
approximate timelines may differ slightly for each clinic. 
 
4.4 Impact on waiting times 
 
The controlled and measured restart has compounded pre COVID-19 waiting list 
times both for patients waiting for fertility treatment, as well as those waiting for 
fertility clinic appointments and investigations (who will often, if appropriate, be added 
to the waiting list). Although extra time is being added to both groups as a result of 
COVID-19,to ensure patients remain eligible for NHS funded IVF, this will not mitigate 
the effect of age on fertility and success rates (Smith et al., 2020) which is significant 
as age advances. 
 
Some patients who have previously had successful NHS treatment and have frozen 
embryos for possible siblings are moving gametes/ embryos to private clinics in order 
to have earlier treatment. This has a financial impact for the NHS as it increases the 
burden on NHS staff to arrange legal documentation and couriers for gametes and 
embryos. 
 
5 Mitigation steps for fertility services 
 
All clinics have undertaken detailed risk assessments with policies and procedures 
put in place to reduce the risk of SARS-CoV-2 transmission 
(https://www.gov.scot/publications/covid-19-fertility-treatment-scotland-plans-
restarting-treatment-framework/). Several service developments and altered working 
practices have been adopted, including: 
 
 Increased use of remote consultations due to restrictions imposed by COVID-
19. Patients are only attending clinics for procedures that cannot be done 
remotely e.g. egg collection, embryo transfer, ultrasound, blood tests, tubal 
patency check and semen analysis. For patients this is convenient, reduces 
travel time and cost in addition to reducing clinic footfall. This restructuring of 
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service provision will continue after the COVID-19 pandemic due to the 
positive impact on patients as well as NHS service delivery 
 
 All meetings are conducted via Microsoft Teams or WebEx, which will continue 
longer term. This has resulted insignificant cost and resourcing efficiencies 
along with improving communication 
 
 Counsellors are providing support through remote consultations and this will 




 Work to introduce an electronic consent system is progressing well with 
support from the Scottish Government. It is expected that electronic consents 
will be live later in 2020. This will significantly reduce staff time used in 
obtaining informed consent and reduce the risk of infection due to reduction in 
face to face clinic contact. This will also help in mitigating the effect of staff 
shortages 
 
NHS staff have been advised that holidays that involve travel overseas will only be 
approved after prior discussion and agreement around self-isolation. 
https://www.sehd.scot.nhs.uk/dl/DL(2020)20.pdf 
 
We will work on the following steps: 
 
5.1 Flu vaccine: 
 
In order to reduce the risk of developing flu, the vaccine will be recommended to all 






At the time of restarting, fertility services commenced with frozen embryo transfers. A 
full explanation for this decision is detailed within restart framework. Those in the 
older age group were subsequently prioritised at the time of restarting services in 
order to provide the best possible chance of a successful treatment outcome. 
A contingency plan will be made by each clinic based on number of staff available in 
each discipline (medical, nursing, admin and laboratory). This plan will be used to 
prioritise clinic activity in the event of staff absence due to winter and COVID-19. 
Although the principles governing this process can be agreed nationally, the decision 
will need to be made by each clinic based on their local risk assessments, as each 
team will need to have critical number to run the service, especially scientists. 
Further discussion and adaptation will be needed locally depending on the timing of a 
second and subsequent wave(s) and where individual clinics are in the restart plan 
when this occurs.  
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Table 1 shows an example of what a local plan may entail. 
Table 1: An example of prioritisation 
Staffing level  Continue  Reduce/Pause 
100% staff  Full activity   
75% staff  Continue those in treatment  
 
Reduce clinics 
50% staff  Fresh IVF ICSI treatments  
Frozen embryo transfer 
Donor inseminations 
Ovulation inductions 




25% staff  Consider pausing Fresh 
IVF/ICSI treatments only* 
Donor inseminations  
Ovulation inductions 
Pause Frozen embryo 
transfers* 
10% staff  Urgent fertility preservation only  Pause all treatments  
*whether fresh or frozen treatments are prioritised will depend on individual clinic staffing in each domain 
As it was anticipated that winter pressures will hit services from November onwards, 
therefore tertiary clinics have utilised a window of opportunity (August to October) to 
prioritise  those who will need face to face appointments, to mitigate against service 
disruption and treatment delay (for example): 
 Those who need ovarian stimulation (fresh IVF treatments) 
 Those requiring face to face appointments for diagnostics such as ultrasound/ 
Blood tests/ semen analysis  
 
5.3 Patients with medical illness 
 
During the initial peak of the pandemic, treatment of those with co-morbidities (e.g. 
well controlled diabetes, or those who were shielding) was postponed however, as 
shielding is no longer required, treatment for these patients has resumed. All clinics 
have systems in place to liaise with obstetric colleagues as and when required for 
those with medical illness and to ensure that an individualised plan is made. 
 
5.4 Increasing capacity 
 
In the restart framework fertility services previously discussed extending the working 
day and week. All clinics will continue to review the situation locally and jointly with 
other clinics, to increase capacity wherever possible with the aim to reach pre 
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COVID-19 waiting times. However, this will need to be done in conjunction with local 
risk assessments and provision of safe services. 
 
Flexibility provided with the increased use of remote consultations and using 
electronic systems will help in reducing waiting times for consultations but may lead 
to a surge in patients placed on the waiting lists for treatment. Centres will further 
explore the use of more electronic systems e.g. In HealthCare and Lensus Digital to 
increase the capacity for more consultations. 
 
5.5 Cross working between clinics 
 
In this speciality, like most tertiary specialities, there are a limited number of staff 
trained to perform procedures. With this in mind, staff absence can reach a critical 
level fairly quickly within smaller teams. Although IVF is a national programme, staff 
are employed by a local health board and are currently unable to travel to other 
clinics without lengthy Human Resources (HR) procedures.  Experience to date has 
been that it can take months to process an honorary contract despite all staff being 
employed within NHS Scotland. It is anticipated that these HR procedures may result 
in cancellation of patient treatment due to staff shortages. 
 
Ideally cross working between clinics would be possible with staff working between 
boards and with appropriate legal cover if an individual has a contract with any health 
board in Scotland. Cross working has also been recommended by the UK 
professional body, the British Fertility Society in their guidance. 
 
Our current contingency plan already allows patients to be transferred between units 
for procedures. This has already happened during the pandemic between the 
Centres in Edinburgh and Dundee. However, in certain situations, it may not be 
possible for patients to travel. 
 
5.6 Communication with Primary care 
 
We have had feedback that primary care colleagues are sometimes unsure as to 
which services are running in secondary and tertiary care.  While some referrals are 
been sent to secondary care, it is possible that others may be holding back referrals. 
This will impact on the pathway and eventual success rates for patients as age is the 
single most important factor affecting success rates.  
 
We will continue to work on communication with primary care so that initial secondary 
care consultations continue. All modalities such as email, intranet/ website update 
and social media will be used. 
 
5.7 Support for patients 
 
Centres will work with Fertility Network UK to continue to support patients during 
these unprecedented and unpredictable times, aiming to provide updates to patients 
by regular webinars hosted by Fertility Network UK and delivered jointly by four 
tertiary clinics. The first one took place on 30th June and a second on 25th August. 
Clinics will continue to frequently update local websites as a method of ensuring 
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patients are provided with up to date information. All clinics have already increased 
capacity to answer phone calls. All counsellors have been working throughout the 
pandemic and will continue to do so remotely. Cross clinic working of counsellors will be 
considered between the clinics as per existing contingency arrangements. 
 
Fertility Network UK has worked tirelessly to provide patient support with an 
increased number of calls, and both SG and clinics are enormously grateful for the 
support they have given to patients and clinics during this period.  
 
5.8 National and international guidance 
 
We are developing national guidance in conjunction with emerging evidence from 
national (BFS) and international professional societies (ESHRE) as well as the advice 
from Scottish Government and Public Health Scotland.  
 
5.9 Donor gametes 
 
Recruitment of donor gametes was put in phase 5 of the restart framework road map. 
This was because recruitment campaigns need significant mobilisation of staff and 
requires donors to come to hospitals thereby putting them at risk of infection, when 
they themselves are healthy. 
Donors will also increase the footfall which in turn may increase risk of transmission. 
 
Given the concerns of winter as highlighted in section 3, it is unlikely that we will be 
able to start recruiting donors until spring 2021.  This will have a major impact on the 
group of patients who require donor gametes.  
 
In Scotland we have worked together with the National Infertility Group and Scottish 
National Blood Transfusion services (SNBTS) to have a centralised storage system 
for gametes and embryos (both for donation and fertility preservation). This will also 
create a central donor gamete bank. SNBTS have received approval by the 
regulatory authority, the HFEA, and this was to have its launch by the Minister for 
Public Heath, Sport and Wellbeing, on the 17th of June 2020 but has been paused 
due to COVID-19. 
 
Plans are in place to get all documentation and processes ready for recruitment for 
donors so that the campaign can be launched as soon as possible, when the risk of 
COVID-19 and concerns with winter are reduced. This will be prioritised as soon as it 
is safe to do so. Centres will look to share the donor gametes they currently have in 
storage at present, where possible. 
 
5.10 Waiting for elective surgery 
 
Those waiting for surgery prior to IVF will continue to have IVF treatment if they can 
safely do so. However, their embryos will be frozen rather than immediate transfer as 
without surgery chances of the implantation are less e.g. hydrosalpinx/ fibroid 
resections.  
Those who need surgery even to facilitate IVF and are nearing the upper age limit to 
access funding, will be escalated through local health boards, if possible.  
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5.11 Self-funded patients 
 
Self-funded patients will be treated in conjunction with local agreed policies and 
previous organisational structures. This will ensure appropriate budgetary 
management and avoid the unnecessary burden of organising specialised transport 
and legal documentation to enable gametes and embryos to be transferred to 
independent sector facilities.  
 
6 Support for staff 
 
Joint teaching sessions  
We will do joint teaching sessions remotely through Microsoft Teams/ Zoom for staff 
across the Scotland rather than just local teachings.  
 
Complex case MDTs 
Complex case MDTs have been set up every Friday morning to discuss cases 
requiring multidisciplinary input and challenging situations. Membership consists of 
patient representatives, clinical academics, clinicians, scientists and government. 
 
Regular meetings  
Regular meetings will continue to happen within ACU leads group(the group 
responsible for this report), once every fortnight or more frequently if needed. 
 
7 Specific Issues 
 
7.1 Face coverings 
 
Face coverings will be used in clinics as set out in Scottish Government and local 
Health Board guidance, both by staff, patients and those accompanying patients for 
support.  
 
If a patient refuses to wear a mask, clinics have the right to refuse to treat them, 
unless there is a medical reason that they cannot wear a mask. Staff and patients 




All training will need to continue during the winter months and beyond. How training 
is delivered will be modified. Wherever possible, electronic modalities will be used, 
however where hands on training and attendance at clinic is required, it will need to 
be accommodated within clinic working. This is in line with RCOG as well as BFS 
guidance. 
 
Everyone attending the clinic will need to adhere to Scottish Government and local 
Health Board guidance. 
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8  Abbreviations 
 
ACU Assisted Conception Unit 
ARCS Association of Reproductive and Clinical Scientists 
BAME Black, Asian and Minority Ethnic 
BFS British Fertility Society 
COVID - 19 Corona Virus Disease 2019 
HFEA Human Fertilisation and Embryology Authority 
HR Human Resources 
ICSI Intracytoplasmic Sperm Injection 
IPC Infection Prevention and Control 
IVF In vitro fertilisation 
MDT Multi-Disciplinary Team 
NHS National Health Service 
PPE Personal Protective Equipment 
PR Person Responsible 
RCOG Royal College of Obstetricians and Gynaecologists 
SARS CoV-2 Severe acute respiratory syndrome coronavirus 2 
SG Scottish Government 
SNBTS Scottish National Blood Transfusion Service 
UK United Kingdom 
UKOSS United Kingdom Obstetrics surveillance system 
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10  Appendix 1: Letter from HFEA to all PRs 
 
HFEA statement on fertility treatment services – effective 13 October 2020 
 
In light of the worrying increase in Covid-19 cases and changes to local lockdown, 
the HFEA wants to provide some reassurance about fertility treatment. 
The changes that clinics put in place from May 2020 onwards, to comply with 
professional guidelines and keep patients safe, mean that we hope a new national 
closure of fertility clinics should not be necessary. 
All HFEA licensed clinics had to set out a Treatment Commencement Strategy in May 
2020 showing how they could provide a safe service for their staff and patients during 
the pandemic.  These strategies are kept under regular review by clinics and our 
inspectors, and all clinics should follow the latest guidance from the UK professional 
bodies - the British Fertility Society and Association of Reproductive and Clinical 
Scientists. 
As the pandemic continues, we recognise that individual clinics may face 
circumstances where they will have to consider whether they can continue to 
maintain a safe service for a period of time – for example if they have a high level of 
staff sickness or their local hospital trust decides to restrict some patient services. 
We expect clinics to follow professional and local guidance and to review and adapt 
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11 Appendix 2:  Tiers 
 
Level 0 (baseline) and Level 1 - Within these levels, we would expect to see low 
incidence of the virus with isolated clusters, and low community transmission. 
Broadly, these levels are the closest we can get to normality, without a vaccine or 
effective treatment in place, before conditions will allow us to move to Phase 4 of the 
Route Map. They would be similar to the measures in place during the summer, once 
we reached Phase 3. The Baseline and Level 1 are designed to be sustainable for 
longer periods.  
 
Levels 2-3  - Within Levels 2 and 3, we would expect to see increased incidence of 
the virus, with multiple clusters and increased community transmission. There would 
be a graduated series of protective measures to tackle the virus, focusing on key 
areas of risk – broadly, indoor settings where household mixing takes place with less, 
or less well-observed, physical distancing and mitigations. The measures would be 
intended to be in place for relatively short periods (2-4 weeks), and only for as long 
as required to get the virus down to a low, sustainable level.  
 
Level 4  - Within this level we would expect to see very high or rapidly increasing 
incidence, and widespread community transmission which may pose a threat to the 
NHS to cope. It is likely that this level would see the introduction of measures close to 
a return to full lockdown. Measures would be designed to be in place for a short 
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Level 0 (baseline) 
and Level 1 
1 - Living with Covid 
Tier 2 - 
Levels 2-3 Enhanced 
Measures depending on 
local virus prevalence 
Tier 3 –  
Level 4:  
Restricted Measures 
Donor recruitment  
 
  
Services resume to pre-
COVID level but with new 
ways of working as 
highlighted in section 5.  
 
Continue with remote 
consultations 
 
Restrict face to face 
appointment  
 
Continue with fertility 
services where staffing 
permits as per HFEA 
guidance and restart plan 
already published 
 
Appropriate use of PPE 
both by patients and staff  
 






Face to face only when 
absolutely necessary 
 
Prioritisation of services 
as per section 5.2 
 
Prioritisation for those at 




preservations to continue 
 
Staff encouraged to work 
from home wherever 
possible 
 
Consideration for freeze 




Appropriate use of PPE 
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